vs

Side-by-side financial comparison of MEDIFAST INC (MED) and RESOURCES CONNECTION, INC. (RGP). Click either name above to swap in a different company.

RESOURCES CONNECTION, INC. is the larger business by last-quarter revenue ($117.7M vs $75.1M, roughly 1.6× MEDIFAST INC). On growth, RESOURCES CONNECTION, INC. posted the faster year-over-year revenue change (-19.2% vs -36.9%). RESOURCES CONNECTION, INC. produced more free cash flow last quarter ($15.6M vs $-6.6M). Over the past eight quarters, RESOURCES CONNECTION, INC.'s revenue compounded faster (-11.8% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

RGP, formerly known as Resources Global Professionals, is the operating arm of Resources Connection, Inc.. The company provides consulting services in the areas of finance & accounting, information management, governance, risk & compliance (GRC), human capital, legal & regulatory, corporate advisory & restructuring, strategic communications, and supply chain management. As of fiscal year ending May 28, 2016, the company employed 3,283 professionals in 68 offices in 20 countries around the wor...

MED vs RGP — Head-to-Head

Bigger by revenue
RGP
RGP
1.6× larger
RGP
$117.7M
$75.1M
MED
Growing faster (revenue YoY)
RGP
RGP
+17.7% gap
RGP
-19.2%
-36.9%
MED
More free cash flow
RGP
RGP
$22.2M more FCF
RGP
$15.6M
$-6.6M
MED
Faster 2-yr revenue CAGR
RGP
RGP
Annualised
RGP
-11.8%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
MED
MED
RGP
RGP
Revenue
$75.1M
$117.7M
Net Profit
$-12.7M
Gross Margin
69.4%
37.1%
Operating Margin
-10.4%
-10.3%
Net Margin
-10.8%
Revenue YoY
-36.9%
-19.2%
Net Profit YoY
81.6%
EPS (diluted)
$-1.64
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
RGP
RGP
Q4 25
$75.1M
$117.7M
Q3 25
$89.4M
$120.2M
Q2 25
$105.6M
$139.3M
Q1 25
$115.7M
$129.4M
Q4 24
$119.0M
$145.6M
Q3 24
$140.2M
$136.9M
Q2 24
$168.6M
$148.2M
Q1 24
$174.7M
$151.3M
Net Profit
MED
MED
RGP
RGP
Q4 25
$-12.7M
Q3 25
$-2.3M
$-2.4M
Q2 25
$2.5M
$-73.3M
Q1 25
$-772.0K
$-44.1M
Q4 24
$-68.7M
Q3 24
$1.1M
$-5.7M
Q2 24
$-8.2M
$10.5M
Q1 24
$8.3M
$2.5M
Gross Margin
MED
MED
RGP
RGP
Q4 25
69.4%
37.1%
Q3 25
69.5%
39.5%
Q2 25
72.6%
40.2%
Q1 25
72.8%
35.1%
Q4 24
74.1%
38.5%
Q3 24
75.4%
36.5%
Q2 24
73.2%
40.2%
Q1 24
72.8%
37.0%
Operating Margin
MED
MED
RGP
RGP
Q4 25
-10.4%
-10.3%
Q3 25
-4.6%
-1.7%
Q2 25
-1.0%
-47.0%
Q1 25
-1.1%
-38.4%
Q4 24
0.6%
-52.7%
Q3 24
1.5%
-3.5%
Q2 24
-4.7%
7.6%
Q1 24
4.5%
2.8%
Net Margin
MED
MED
RGP
RGP
Q4 25
-10.8%
Q3 25
-2.5%
-2.0%
Q2 25
2.3%
-52.6%
Q1 25
-0.7%
-34.0%
Q4 24
-47.2%
Q3 24
0.8%
-4.2%
Q2 24
-4.8%
7.1%
Q1 24
4.8%
1.7%
EPS (diluted)
MED
MED
RGP
RGP
Q4 25
$-1.64
$-0.38
Q3 25
$-0.21
$-0.07
Q2 25
$0.22
$-2.21
Q1 25
$-0.07
$-1.34
Q4 24
$0.08
$-2.08
Q3 24
$0.10
$-0.17
Q2 24
$-0.75
$0.31
Q1 24
$0.76
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
RGP
RGP
Cash + ST InvestmentsLiquidity on hand
$167.3M
$89.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$194.6M
Total Assets
$248.0M
$289.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
RGP
RGP
Q4 25
$167.3M
$89.8M
Q3 25
$173.5M
$77.5M
Q2 25
$162.7M
$86.1M
Q1 25
$164.6M
$72.5M
Q4 24
$162.3M
$78.2M
Q3 24
$170.0M
$89.6M
Q2 24
$163.5M
$108.9M
Q1 24
$156.4M
$113.8M
Stockholders' Equity
MED
MED
RGP
RGP
Q4 25
$198.9M
$194.6M
Q3 25
$214.7M
$206.4M
Q2 25
$216.0M
$207.1M
Q1 25
$211.0M
$277.8M
Q4 24
$210.1M
$325.7M
Q3 24
$207.3M
$407.2M
Q2 24
$205.3M
$418.8M
Q1 24
$211.0M
$414.9M
Total Assets
MED
MED
RGP
RGP
Q4 25
$248.0M
$289.3M
Q3 25
$268.2M
$287.2M
Q2 25
$269.3M
$304.7M
Q1 25
$280.0M
$375.6M
Q4 24
$284.2M
$424.9M
Q3 24
$291.2M
$512.9M
Q2 24
$293.5M
$510.9M
Q1 24
$302.8M
$523.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
RGP
RGP
Operating Cash FlowLast quarter
$-5.3M
$15.9M
Free Cash FlowOCF − Capex
$-6.6M
$15.6M
FCF MarginFCF / Revenue
-8.8%
13.2%
Capex IntensityCapex / Revenue
1.8%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$24.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
RGP
RGP
Q4 25
$-5.3M
$15.9M
Q3 25
$12.1M
$-7.8M
Q2 25
$-3.4M
$16.8M
Q1 25
$3.4M
$659.0K
Q4 24
$-4.9M
$1.8M
Q3 24
$9.1M
$-309.0K
Q2 24
$13.1M
$3.2M
Q1 24
$7.3M
$20.5M
Free Cash Flow
MED
MED
RGP
RGP
Q4 25
$-6.6M
$15.6M
Q3 25
$10.8M
$-8.0M
Q2 25
$-4.8M
$16.5M
Q1 25
$1.9M
$238.0K
Q4 24
$-7.2M
$61.0K
Q3 24
$7.7M
$-575.0K
Q2 24
$11.1M
$3.0M
Q1 24
$5.4M
$20.4M
FCF Margin
MED
MED
RGP
RGP
Q4 25
-8.8%
13.2%
Q3 25
12.0%
-6.6%
Q2 25
-4.5%
11.8%
Q1 25
1.6%
0.2%
Q4 24
-6.1%
0.0%
Q3 24
5.5%
-0.4%
Q2 24
6.6%
2.1%
Q1 24
3.1%
13.5%
Capex Intensity
MED
MED
RGP
RGP
Q4 25
1.8%
0.3%
Q3 25
1.5%
0.1%
Q2 25
1.3%
0.2%
Q1 25
1.3%
0.3%
Q4 24
1.9%
1.2%
Q3 24
1.0%
0.2%
Q2 24
1.1%
0.1%
Q1 24
1.1%
0.1%
Cash Conversion
MED
MED
RGP
RGP
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
0.30×
Q1 24
0.88×
8.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

RGP
RGP

US$93.7M80%
Non Us$24.0M20%

Related Comparisons